Coloplast A/S's latest marketcap:
As of 06/26/2025, Coloplast A/S's market capitalization has reached $21.29 B. According to our data, Coloplast A/S is the 996th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 21.29 B |
| Revenue (ttm) | 4.35 B |
| Net Income (ttm) | 711.56 M |
| Shares Out | 225.17 M |
| EPS (ttm) | 3.16 |
| Forward PE | 24.15 |
| Ex-Dividend Date | 05/08/2025 |
| Earnings Date | 08/19/2025 |
Coloplast A/S's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | kr21.29 B | -22.45% | 996 |
| 12/30/2024 | kr177 B | 2.05% | 783 |
| 12/29/2023 | kr173.44 B | 0.54% | 702 |
| 12/30/2022 | kr172.51 B | -29.57% | 678 |
| 12/30/2021 | kr244.93 B | 23.89% | 529 |
| 12/30/2020 | kr197.71 B | 12.62% | 543 |
| 12/30/2019 | kr175.55 B | 36.63% | 543 |
| 12/28/2018 | kr128.48 B | 22.65% | 593 |
| 12/29/2017 | kr104.75 B | 3.71% | 773 |
| 12/30/2016 | kr101.01 B | -14.23% | 725 |
Company Profile
About Coloplast A/S
Coloplast A/S is a global leader in developing and selling intimate healthcare products and services. Headquartered in Humlebæk, Denmark, the company operates in multiple countries, including Denmark, the United States, the United Kingdom, and France.
Business Segments
- Chronic Care: Focuses on ostomy care solutions.
- Continence Care: Provides products for urinary and bowel management.
- Voice and Respiratory Care: Offers solutions for laryngectomy and tracheostomy care.
- Interventional Urology: Specializes in surgical treatments for urological and gynecological disorders.
- Advanced Wound Care: Delivers innovative wound and skin care products.
Key Products
- Ostomy Care: SenSura Mio, SenSura Ostomy care solutions, and Brava accessories.
- Continence Care: Conveen Active urine bags, SpeediCath catheters, and Peristeen Plus.
- Wound & Skin Care: Biatain Silicone dressings, Comfeel hydrocolloid dressings, and InterDry skin fold management.
- Voice & Respiratory: Provox voice prostheses, Tracoe tracheostomy products, and HMEs.
- Interventional Urology: Solutions for urinary stone diseases, benign prostate hyperplasia, and erectile dysfunction.
Founded in 1954, Coloplast A/S continues to innovate in intimate healthcare, improving quality of life for patients worldwide.
Frequently Asked Questions
-
What is Coloplast A/S's (CPH-COLO.B) current market cap?As of 06/26/2025, Coloplast A/S (including the parent company, if applicable) has an estimated market capitalization of $21.29 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Coloplast A/S (CPH-COLO.B) rank globally by market cap?Coloplast A/S global market capitalization ranking is approximately 996 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.